Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Cut to $6.50 by Analysts at Canaccord Genuity Group

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price cut by Canaccord Genuity Group from $7.00 to $6.50 in a research note released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

BIOX has been the topic of several other research reports. Lake Street Capital decreased their price target on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, February 7th. Oppenheimer cut their price objective on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a report on Tuesday, January 28th. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $9.88.

Bioceres Crop Solutions Price Performance

NASDAQ:BIOX opened at $4.74 on Thursday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27. The company has a 50-day moving average of $6.53 and a 200-day moving average of $7.68. Bioceres Crop Solutions has a 52 week low of $4.66 and a 52 week high of $13.80. The company has a market capitalization of $297.25 million, a price-to-earnings ratio of 237.12 and a beta of 0.57.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The business had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. During the same quarter in the prior year, the business earned ($0.07) EPS. As a group, equities research analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several institutional investors have recently bought and sold shares of BIOX. Jump Financial LLC acquired a new stake in shares of Bioceres Crop Solutions in the fourth quarter valued at $72,000. Ping Capital Management Inc. grew its holdings in Bioceres Crop Solutions by 7.3% during the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after acquiring an additional 3,000 shares during the last quarter. Stifel Financial Corp increased its position in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after acquiring an additional 10,224 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Bioceres Crop Solutions by 17.0% in the fourth quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock worth $640,000 after acquiring an additional 15,328 shares during the last quarter. Finally, Ballast Asset Management LP lifted its position in shares of Bioceres Crop Solutions by 23.5% during the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock worth $2,620,000 after purchasing an additional 82,187 shares in the last quarter. Institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.